Customize your search results with filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 02/19/2023

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

Combined atezolizumab and nab-paclitaxel in the treatment of triple negative breast cancer: a meta-analysis on their efficacy and safety.

Condition: Triple Negative Breast Cancer (TNBC)
Journal: BMC cancer
Treatment Used: Combined Atezolizumab and Nab-Paclitaxel
Number of Patients: 0
Published: November 06, 2022

Metastatic triple negative breast cancer with NTRK gene fusion on tissue but not on ctDNA molecular profile.

Condition: Metastatic Triple Negative Breast Cancer with NTRK Gene Fusion
Journal: BMJ case reports
Treatment Used: Larotrectinib
Number of Patients: 1
Published: October 12, 2022

The effect of chemotherapy on survival in oldest old patients with nonmetastatic triple negative breast cancer: A populationbased observational study.

Condition: Nonmetastatic Triple Negative Breast Cancer (TNBC) in Patients Aged 80 Years and Over
Journal: Journal of clinical pharmacy and therapeutics
Treatment Used: Chemotherapy
Number of Patients: 1611
Published: September 29, 2022

Moment of truth-adding carboplatin to neoadjuvant/adjuvant chemotherapy in triple negative breast cancer improves overall survival: An individual participant data and trial-level Meta-analysis.

Condition: Triple Negative Breast Cancer (TNBC)
Journal: Breast (Edinburgh, Scotland)
Treatment Used: Carboplatin Added to Neoadjuvant Chemotherapy
Number of Patients: 2425
Published: April 24, 2022

The impact of chemotherapy and survival prediction by machine learning in early Elderly Triple Negative Breast Cancer (eTNBC): a population based study from the SEER database.

Condition: Early Elderly Triple Negative Breast Cancer (eTNBC)
Journal: BMC geriatrics
Treatment Used: Chemotherapy
Number of Patients: 4696
Published: April 01, 2022

Combined angiogenesis and PD-1 inhibition for immunomodulatory TNBC: concept exploration and biomarker analysis in the FUTURE-C-Plus trial.

Condition: Triple-Negative Breast Cancer (TNBC
Journal: Molecular cancer
Treatment Used: Immunotherapy
Number of Patients: 48
Published: March 26, 2022

Additional capecitabine use in early-stage triple negative breast cancer patients receiving standard chemotherapy: a new era? A meta-analysis of randomized controlled trials.

Condition: Early-Stage Triple Negative Breast Cancer (eTNBC)
Journal: BMC cancer
Treatment Used: Additional Capecitabine
Number of Patients: 3329
Published: March 13, 2022

Triple-negative Breast Cancer (TNBC) and Its Luminal Androgen Receptor (LAR) Subtype: A Clinicopathologic Review of Cases in a University Hospital in Northwestern Nigeria.

Journal: Nigerian journal of clinical practice
Published: January 20, 2022

Targeting prooxidant MnSOD effect inhibits triple-negative breast cancer (TNBC) progression and M2 macrophage functions under the oncogenic stress.

Journal: Cell death & disease
Published: January 12, 2022

IFI16 inhibits DNA repair that potentiates type-I interferon-induced antitumor effects in triple negative breast cancer.

Journal: Cell reports
Published: December 22, 2021

One-Year Toxicity Report of the RADIOPARP Phase I Trial Evaluating Olaparib With Radiotherapy for Triple Negative Breast Cancer.

Condition: Triple Negative Breast Cancer (TNBC)
Journal: International journal of radiation oncology, biology, physics
Treatment Used: Olaparib with Radiotherapy
Number of Patients: 24
Published: October 27, 2021

Identification of the Novel Tumor Suppressor Role of FOCAD/miR-491-5p to Inhibit Cancer Stemness, Drug Resistance and Metastasis via Regulating RABIF/MMP Signaling in Triple Negative Breast Cancer.

Journal: Cells
Published: October 23, 2021
Showing 1-12 of 32

Last Updated: 02/19/2023